Eluvixtamab (AMG-330)
Revision as of 01:18, 29 February 2020 by Warner-admin (talk | contribs)
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3